Latest Payment Processing News

Lynch Group Holdings confirms Federal Court approval of its acquisition scheme by Darwin Aus Bidco, with shares suspended and a cash payout scheduled. Shareholders await the next steps as the deal moves toward implementation.

QuickFee Limited has announced a shareholder-approved return of capital totaling approximately A$28.5 million, funded by proceeds from the sale of its US Pay Now and Connect businesses. Shareholders will receive 7.5 cents per share, with payments scheduled for early December.

Cuscal Limited has received final regulatory approval from APRA for its full acquisition of Indue Limited, setting the stage for completion by early December.

VanEck Investments Limited has announced dividend payments and dividend reinvestment plan (DRP) prices for 11 of its exchange traded funds, outlining important dates for investors to note.

SportsHero has launched its iGV Game Pass subscription in the Philippines through a strategic partnership with PLDT Home, tapping into a booming PC gaming market.

Smartpay Holdings Limited’s shares have been suspended from the ASX following New Zealand’s High Court approval of its acquisition by Shift4 Holdings Limited, marking a significant milestone in the payment processing sector.

Microba Life Sciences reports robust Q1 FY26 growth in microbiome diagnostics, introduces workflow-enhancing features, and prepares for key therapeutic deal catalysts by year-end.

Cuscal Limited has secured a crucial regulatory win as the ACCC clears its full acquisition of Indue Limited, setting the stage for completion by year-end pending final approvals.

The Federal Court has approved QGold’s compulsory acquisition of Carawine Resources’ remaining shares at 11 cents each, setting the stage for Carawine’s imminent ASX suspension and delisting.

The Federal Court has approved QGold’s compulsory acquisition of Carawine Resources’ remaining shares, paving the way for the company’s imminent delisting from the ASX.

Australia and New Zealand Banking Group Limited (ANZ) has announced a quarterly distribution of AUD 1.2556 per security on its capital notes, with a 70% franking rate and payment scheduled for December 22, 2025.

Telix Pharmaceuticals secures Transitional Pass-Through payment status for its next-generation prostate cancer imaging agent Gozellix, paving the way for broader US patient access and streamlined provider reimbursement.